ERBB2 c.2545C>T ;(p.R849W)

Variant ID: 17-37881353-C-T

NM_004448.2(ERBB2):c.2545C>T;(p.R849W)

This variant was identified in 4 publications

View GRCh38 version.




Publications:


Design of a Potent, Selective, and Brain-Penetrant Inhibitor of Wnt-Deactivating Enzyme Notum by Optimization of a Crystallographic Fragment Hit.

Journal Of Medicinal Chemistry
Willis, Nicky J NJ; Mahy, William W; Sipthorp, James J; Zhao, Yuguang Y; Woodward, Hannah L HL; Atkinson, Benjamin N BN; Bayle, Elliott D ED; Svensson, Fredrik F; Frew, Sarah S; Jeganathan, Fiona F; Monaghan, Amy A; Benvegnù, Stefano S; Jolly, Sarah S; Vecchia, Luca L; Ruza, Reinis R RR; Kjær, Svend S; Howell, Steven S; Snijders, Ambrosius P AP; Bictash, Magda M; Salinas, Patricia C PC; Vincent, Jean-Paul JP; Jones, E Yvonne EY; Whiting, Paul P; Fish, Paul V PV
Publication Date: 2022-05-26

Variant appearance in text: HER2: R849W
PubMed Link: 35536179
Variant Present in the following documents:
  • jm2c00162_si_001.pdf
View BVdb publication page



Galiellalactone inhibits the STAT3/AR signaling axis and suppresses Enzalutamide-resistant Prostate Cancer.

Scientific Reports
Thaper, Daksh D; Vahid, Sepideh S; Kaur, Ramandeep R; Kumar, Sahil S; Nouruzi, Shaghayegh S; Bishop, Jennifer L JL; Johansson, Martin M; Zoubeidi, Amina A
Publication Date: 2018-11-23

Variant appearance in text: HER2: R849W
PubMed Link: 30470788
Variant Present in the following documents:
  • 41598_2018_Article_35612.pdf
View BVdb publication page



Discovery of the novel autophagy inhibitor aumitin that targets mitochondrial complex I.

Chemical Science
Robke, Lucas L; Futamura, Yushi Y; Konstantinidis, Georgios G; Wilke, Julian J; Aono, Harumi H; Mahmoud, Zhwan Z; Watanabe, Nobumoto N; Wu, Yao-Wen YW; Osada, Hiroyuki H; Laraia, Luca L; Waldmann, Herbert H
Publication Date: 2018-03-21

Variant appearance in text: HER2: R849W
PubMed Link: 29732085
Variant Present in the following documents:
  • SC-009-C7SC05040B-s001.pdf
View BVdb publication page



HER2 somatic mutations are associated with poor survival in HER2-negative breast cancers.

Cancer Science
Wang, Tonghui T; Xu, Ye Y; Sheng, Shuyan S; Yuan, Hua H; Ouyang, Tao T; Li, Jinfeng J; Wang, Tianfeng T; Fan, Zhaoqing Z; Fan, Tie T; Lin, Benyao B; Xie, Yuntao Y
Publication Date: 2017-04

Variant appearance in text: HER2: R849W
PubMed Link: 28164408
Variant Present in the following documents:
  • Main text
  • CAS-108-671.pdf
View BVdb publication page